The objective of this study was to evaluate and compare the anti-diabetic effi cacy of feeding diets supplemented with okara and soybean bran to ICR mice with experimentally-induced type 2 diabetes. While okara and soybean bran are from the same source, there is no performed research comparing the effects of these soybean byproducts on glycemic status. Normal and streptozotocin-induced type 2 diabetic ICR mice were assigned either to a normal diet in the normal control group, a high fat diet only in the diabetic control group, a high fat diet supplemented with 15% okara in the okara group, a high fat diet supplemented with 15% soybean bran in the soybean bran group or a high-fat diet supplemented with 0.1% metformin in the metformin group for 8 weeks. The biochemical parameters, the organs relative weights and liver histological structure of mice were determined. Okara was signifi cantly effective in controlling hyperglycemia and improving glucose tolerance. Moreover, the antihyperglycemic effect of okara was broadly comparable with the actions of metformin. Feeding okara and soybean bran caused hypolipidemic effects. In addition, they had a strong cytoprotective effect on hepatocytes. Soybean bran seemed more effi cient than okara in alleviating hepatic cell histological changes. Results demonstrated the potential benefi t of okara and soybean bran in glycemic control and reducing the risk of type 2 diabetes complications.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a disease caused by relative lack of insulin or a loss of insulin function in various organs, resulting in many clinical symptoms as well as malfunctioning metabolism in carbohydrate, lipid and protein [Murotomi et al., 2015] . Dietary interference is one of the most important therapies suggested for the patient with T2DM [Tucker et al., 2014] . The target of the diet therapy is not only to reduce body weight, but also to achieve a benefi cial role against the major defects of T2DM, such as insulin resistance, hyperglycemia and hyperlipidemia [Cicek et al., 2009] . High-fi ber diets from a variety of foods could reduce fasting plasma glucose [Kiehm et al., 1976] , cholesterol and triacylglycerol levels [Anderson & Ward, 1979] . The glucose tolerance could be signifi cantly improved by the addi-tion of dietary fi ber source into the test meals of both healthy and diabetic subjects [Mahalko et al., 1984] . Moreover, a considerable reduction was observed in postprandial glucose and insulin level in rats after two-week feeding of guar or carboxymethyl cellulose [Cannon et al., 1980] . Dietary fiber could reduce the rate of diffusion of digestion products towards the absorptive mucosal surface and enhance the release of gastrointestinal hormones affecting glucose metabolism [Madar, 1983] .
Soybean-based foods have well-documented beneficial effects on human health and currently the consumption of soybean products elevated due to functional food improving knowledge [Dueñas et al., 2012] . As a good source of dietary fi ber, soybean bran is a major co-product of the soybean processing industry and made from soybean hull (seed coat of soybeans). It constitutes about 8% of the whole seed and contains about 86% complex carbohydrates. Soy hull, as a source of dietary fi ber, could increase the plasma high density lipoprotein cholesterol of type 2 diabetic subjects [Mahalko et al., 1984] .
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Okara is the insoluble residue of the production of soy milk from soybean [Yogo et al., 2011] and mainly rich in dietary fiber (50-60%) and protein (30%) [Préstamo et al., 2007] . Its dietary fi ber has 12% hemicellulose, 5.6% cellulose, 12% lignin, and 0.16% phytic acid [Surel & Couplet, 2005] . Because of its high fi ber content, okara can be used as a supplement in human diets, particularly western diets, which are defi cient of the essential fi ber [Préstamo et al., 2007] . T h ere were only a limited number of studies on antidiabetic effect of okara [Ahmad et al., 2010; Lemes et al., 2014] . They indicated that the okara diet might be of great benefi cial effects on glycemic control, preventing glucose intolerance and reducing the risk of diabetic complications, such as hypercholesterolemia.
While okara and soybean bran are from the same source, there is no performed research comparing the effects of these soybean byproduct on glycemic status. Therefore, comparison study is needed to clarify the differences in their antidiabetic effects in order to develop suitable foods for type 2 diabetic patients. The objective of this study was to evaluate and compare the anti-diabetic effi cacy of feeding diets supplemented with soybean bran or okara to ICR mice with experimentally-induced type 2 diabetes.
MATERIALS AND METHODS

Diet preparation
Fresh okara was obtained from a tofu production supplier at Huazhong Agricultural University (Wuhan, Hubei, China). Firstly, okara was dried in an air blowing thermostatic oven (DHG-9240A, Jinghong Experiment Equipment Industry Co., Ltd., Shanghai, China) at 60°C for 24 h with 3 h interval stirring. Then it was ground to fi ne powder using a 200 g portable grinder (Lin Da Machinery Ltd. of Wenling, Zhejiang, China) for 3 min. Ground okara was sieved through an 80 mesh sieve and stored in polyethylene bags. Soybean bran was ground and sieved as the above method. The preparation of experimental diets was done by adding 15% of okara, 15% of soybean bran or 0.1% of metformin, metformin hydrochloride (Beijing Zhonghui Pharmaceutical Co., Beijing, China) into the high-fat diet (HFD). Table 1 includes the compositions of normal, high-fat and experimental diets.
Animals and experimental design
A total number of 60 ICR male mice (three-week old and 18-20 g body weight) were obtained from Hunan Slack Laboratory Animals Co., Ltd. (Changsha, Hunan, China) and kept in a temperature-and humidity-controlled facility. Diets and tap water were provided ad libitum. All procedures were performed in accordance with the guidelines on the ethical use of animals issued by the Animal Care and Use Committee of Huazhong Agricultural University. After all mice were fed the normal diet (Table 1) within one week of habituation to the study environment, 10 mice were selected randomly and received continuous feeding of a normal diet performed as a normal control group (NCG). In order to develop the diabetic animal model, the remaining mice were fed with highfat diet (HFD) for additional six weeks (4 weeks before STZ injection and 2 weeks after injection). Diabetes was induced by an intraperitoneal injection of fi ve daily consecutive multiple low doses of freshly prepared streptozotocin (STZ) (40 mg/kg body weight, Aladdin Biological Technology, Co., Ltd. Shanghai, China) dissolved in 0.1 mol/L citrate buffer (pH 4.4) [Jin et al., 2014] . The animals with fasting blood glucose (FBG) level >7.0 mmol/L were considered as T2DM.
Experimental groups
The experimentally-induced type 2 diabetic mice were divided into four groups, 10 mice in each. Mice in the fi rst group con-TABLE 1. Composition of the normal diet, high-fat diet, okara diet, soybean bran diet, and metformin diet.
Component
Normal tinued feeding with HFD which served as the diabetic control group (DCG). The second group was fed HFD supplemented with 15% okara (HF-OKG). The third group was fed with HFD supplemented with 15% soybean bran (HF-SBG). The fourth group was fed with HFD supplemented with 0.1% metformin (HF-MEG). All mice were maintained on their own diet for another eight weeks. The high-fat diet supplemented with metformin was kept at 4°C to make sure the stability of drug.
Measurements of food intake, water consumption and body weight Daily fl uid and food intake were measured during the entire experimental period. The mouse body weight was recorded weekly by an electronic balance, while the food and water intake were calculated every day by subtracting the remaining amounts from the one supplied at the same time during the experimental period.
Fasting blood glucose
Fasting blood glucose level of each mouse from different groups was measured weekly after overnight 12-h fasting period. The bl ood sample was collected after a cut was made on the tail. Blood glucose level was determined using an AccuChek Active blood glucose meter and active test strips (Roche Diagnostic GmbH, Mannheim, Germany).
Oral glucose tolerance test (OGTT)
The OG TT was conducted at week 7 of the experiment period. The mice in all groups were weighed and fasted from the feed for 12 h. D-glucose solution (50%, 2 g/kg body weight) was administrated orally to fasting mice using a 20-gauge stainless steel gavages feeding needle. The blood sample was collected from a tail-cut, while the blood glucose levels were measured at time 0, 30, 60, and 120 min after glucose administration.
Insulin tolerance test (ITT)
The IT T was performed at week 7. After 4-h fasting, insulin (0.375 IU/kg, NovoRapid 30 asparaginyl, Novo Nordisk Company, Denmark) was dosed to the mice at 5 mL/kg via subcutaneous injection. The blood-glucose levels were measured by collecting blood samples from the tail-cut after insulin injection (0, 30, 60, and 120 min).
Animal sacrifi ce
At the end of the study period, mice were fasted overnight for 12 h and then sacrifi ced. The eyeballs of the mice were removed and blood was drawn. After bleeding, mice were euthanized by cervical decapitation. The samples of liver, kidney, heart, spleen, pancreas and epididymal fat were washed with 0.85% cold saline, dried with fi lter paper, weighed, and immediately frozen and preserved at -20°C until further analysis. Serum samples were collected after the centrifugation (Avanti J-E centrifuge, Beckman Coulter, Inc., USA) of the blood for 10 min at 3,000 rpm and stored at -20°C for further analysis.
Measurement of serum insulin level
Serum insulin level was measured by an enzyme-linked immunosorbent assay (ELISA) procedure using mouse insulin (INS) ELISA kit (Linco Research Inc., Billerica, MA, USA).
Determination of hepatic glycogen content
Fresh liver was rinsed in 0.85% saline, while excess water was wiped by fi lter paper. Liver (50 mg) was mixed with 3 time volume of 30% KOH solution and heated by boiling water at 100°C for 20 min, until the liver completely dissolved. The hepatic glycogen content was measured with a glycogen kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) following the manufacturer's instruction.
Lipid p rofi le measurements
Normal and experimentally induced type 2 diabetic mouse serum samples were analyzed to determine lipid profi le levels. Total cholesterol (TC), triacylglycerol (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were measured with commercial kits (Rongsheng Biotech, Co., Ltd., Shanghai, China) using an Automatic Biochemistry Analyzer (Hitachi 7020, Tokyo, Japan). Serum apolipoprotein A (apoA) and apolipoprotein B (apoB) levels were analyzed by the immunoturbidimetric immunoassay using a commercial kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
Histological study
After animals had been sacrifi ced, the livers from all mice were collected for histological analysis. The liver sections were fi xed in 4% paraformaldehyde overnight and then embedded in paraffi n. Those samples were stained with hematoxylin and eosin according to the routine protocol and examined under a light microscope (Humanoid Nikon E100, Tokyo, Japan).
Statistical analysis
All experiments were performed in duplicate. The data were analyzed by a statistical software package SPSS 19.0 for Windows. One-way ANOVA analysis was used to determine the signifi cant difference between groups and Duncan's multiple range tests to perform multiple comparisons between means, and differences were considered to be statistical signifi cant at p<0.05.
RESULTS
Measurements of food intake, water consumption and body weight
The main symptoms of type 2 diabetes include increased hunger, thirst and unexplained weight loss. Figure 1 shows the effects of feeding okara and soybean bran on food intake, water consumption and body weight of ICR mice with experimentally-induced type 2 diabetes. There was no signifi cant difference in food intake between HF-OKG and HF-MEG per mouse per day over the 8-week experimental period, while the food intake was lower in HF-SBG, NCG and DCG than that in HF-OKG and HF-MEG ( Figure 1A ). The mice might not prefer the high-fat diet with soybean bran, compared to these with okara and metformin. The addition of okara into the high-fat diet signifi cantly increased food intake by mice. Figure 1B shows water consumption per mouse per day among different groups. The fl uid intake was signifi cantly higher in HF-OKG, HF-SBG, HF-MEG and DCG compared to NCG (p<0.05) throughout the same period. Furthermore, there was a signifi cant increase in water consumption by day 43 in DCG. There was no signifi cant difference in water consumption between HF-OKG and HF-SBG, but the average amount of water consumption was signifi cantly lower in HF-OKG and HF-SBG than DCG. The addition of okara to the diet caused health recovery in the mice, which resulted in lowering the water intake.
The normal control mice continued to increase weight consistently to the end of the experiment ( Figure 1C ). There was a signifi cant difference in the body weight (p<0.05) between the NCG and all diabetic groups during 8-week experimental period. HF-OKG, HF-SBG and HF-MEG gradually increased weight until the end of the experiment, while the diabetic control mice continued losing weight. Body weights of HF-OKG were signifi cantly higher than those of HF-SBG. There was no signifi cant difference in body weight between HF-SBG and HF-MEG during most of study period, while there was a signifi cant difference between HF-MEG and HF-OKG in week 3 and 5 only. Okara, soybean bran or metformin gradually increased body weights of diabetic mice.
Fasting blood glucose, oral glucose and insulin tolerance tests
Measurement of fasting blood glucose is a simple analysis for detecting changes in glucose metabolism and is considered as the principal routine test for diabetes mellitus. Figure 2A shows the effect of okara or soybean bran on blood glucose levels in ICR mice with experimentally-induced type 2 diabetes. The FBG levels in NCG were signifi cantly lower than in all diabetic groups (p<0.05). As expected, the FBG levels in the HF-OKG, HF-SBG and HF-MEG were decreased during 8-week period. After 3-week feeding with the diets containing okara, soybean bran or metformin, a signifi cant reduction in FBG levels of mice was detected compared with the DCG. The impact of okara on FBG was similar to that of metformin but higher than of soybean bran.
The OGTT evaluates the disposal of a glucose load administered via oral dosing. Figure 2B illustrates the blood glucose responses to an OGTT after 7-week feeding experimental diets. The blood glucose level in DCG after a glucose load was higher than in all other groups. The blood glucose of DCG reached a peak value 30 min after glucose load and decreased to the lowest level at 120 min. The HF-OKG, HF-SBG and HF-MEG showed a signifi cant increase in the rate of glucose clearance as compared to DCG. Okara, soybean bran and metformin showed the similar glucose clearance rate, but a signifi cant difference in blood glucose level appeared between NCG and those diet groups. Okara, soybean bran and metformin result in a good disposal of a glucose load compared to DCG that were kept on a high-fat diet. The ITT monitors glucose concentration over time, in response to insulin. Figure 2C shows the results of the insulin response test among different groups. The insulin tolerance test was conducted on 4-h fasted mice. Initially, the blood glucose concentration was the lowest in NCG and the highest in DCG. In the diabetic control group, the blood glucose concentrations were increased after injecting insulin and extended until 60 min, then slightly decreased at 120 min. The blood glucose levels in HF-OKG, HF-SBG and HF-MEG decreased successively after injecting insulin, indicating that they had higher sensitivity of response to the insulin than DCG mice.
In the HF-SBG, however, the decrease of the blood glucose showed a delay compared with HF-OKG and HF-MEG. The response of HF-OKG to the administered insulin was more sensitive than that of HF-SBG.
Measurements of serum insulin and hepatic glycogen
Serum insulin level is detected for the glucose metabolism changes in the diabetic subject. Figure 3A shows the effect of okara or soybean bran supplementation on serum insulin levels in experimentally-induced type 2 diabetic ICR mice. Serum insulin levels were signifi cantly lower in DCG as compared with NCG, HF-OKG, HF-SBG and HF-MEG after 8-week feeding with test diets, while serum insulin level of HF-OKG, HF-SBG or HF-MEG was signifi cantly lower than that of NCG. Okara and soybean bran had a similar effect on insulin level, but both were less effective than metformin. Therefore, okara and soybean bran could enhance the insulin secretion.
Glycogen content can be signifi cantly changed upon glucose homeostasis disruption in diabetes. Figure 3B shows the effect of okara, soybean bran and metformin on hepatic glycogen content. Liver glycogen content was signifi cantly higher in HF-OKG, HF-SBG, HF-MEG or NCG than the one in DCG. However, glycogen content in HF-SBG was similar to that in NCG but higher than that in HF-OKG or HF-MEG. Results indicated that soybean bran and okara positively regulated the glycogenesis pathway in the liver through improving the insulin secretion. 
Lipid profi le measurements
Comparing to normal, the diabetic mice usually have lower high-density lipoprotein and higher total cholesterol, triacylglycerol, and low-density lipoprotein and this is m ainly a consequence of insulin resistance, which affects enzyme and lipid metabolism [Bardini et al., 2012] . Figure 4 shows the lipid profi les of the fi ve groups at the end of the experimental period. TC ( Figure 4A ), TG ( Figure 4B ) and LDL ( Figure 4D ) levels were signifi cantly lower in HF-OKG or HF-SBG than in DCG, but higher than in NCG. The HF-OKG or HF-SBG had a higher HDL level than DCG ( Figure 4C ), but lower than that in NCG and HF-MEG. In general, the apoA level is signifi cantly reduced in diabetics, but the improvement of glycemic control raises the apoA levels. Table 2 demonstrates the effect of okara and soybean bran on apo lipoprotein A and apo lipoprotein B secretion in mice with experimentally-induced type 2 diabetes. In this study, apoA concentration was signifi cantly increased in mice fed the normal diet, HFD supplemented with okara, soybean bran or metformin, compared with the DCG fed HFD only. Conversely, a signifi cant difference was observed in the fi nal values of the apoB concentration among all diabetic groups ( Table 2 ). The apoB/apoA ratio values of all mice in different groups indicated that feeding the normal diet, HFD supplemented with okara, soybean bran or metformin caused a signifi cant decrease in apoB/ apoA ratio compared with the diabetic mice fed HFD only (Table 2) . Table 3 illustrates the relative weight comparisons of liver, epididymal fat, heart, kidney, pancreas and spleen of mice with different treatments. The relative liver weight of mice in DCG was signifi cantly higher than in all other groups (p<0.05). Okara and soybean bran had similar effects on relative liver weight. There was a signifi cant difference in the relative epididymal fat weight between NCG and other diabetic groups. The relative heart weight in DCG was signifi cantly lower than in other groups. There was a signifi cant difference (p<0.05) in NCG, HF-OKG and HF-SBG relative kidney weight compared to DCG and HF-MEG. The pancreas relative weight was signifi cantly different in NCG, HF-OKG, HF-SBG and HF-MEG compared to DCG. There was no signifi cant difference in relative spleen weight among HF-OKG and HF-SBG. However, the relative weight of spleen was signifi cantly higher in DCG compared to other diabetic groups and NCG. Liver and kidney relative weights were higher in STZ-induced diabetic animals but the feeding of okara or soybean bran supplementation reversed the increase in the relative weights of these organs. Figure 5 demonstrates the histological changes in hepatocytes of the fi ve groups at the end of the experimental period. Examination of mouse liver biopsy revealed normal arrangement of the hepatocytes with no visible lesion in liver of NCG ( Figure 5A ), while hepatocytes in the DCG showed severe degeneration, numbers of lipid droplets, necrosis, hepatocellular swelling and infl ammatory cell infi ltrate ( Figure 5B ). Liver cells from HF-MEG ( Figure 5C ) were arranged neatly and reduced or eliminated lipid droplets without significant infl ammation or hepatocellular swelling. A similar improvement was observed among the HF-SBG ( Figure 5D ) and the HF-OKG ( Figure 5E ). Interestingly, administration of soybean bran or okara effectively decreased lipid droplets without signifi cant infl ammation or hepatocellular swelling. However, soybean bran was more effective than okara in reducing hepatic cell histological changes. The histological examination of mouse hepatic tissues in HF-SBG showed less lipid droplets compared to HF-OKG. Therefore, effects of okara and soybean bran on liver suggested their favorable hepatoprotective effects on mice with type 2 diabetes induced by a high-fat diet and streptozotocin.
Organs and epididymal fat weights
Histological study
DISCUSSION
In this study, normal or experimentally-induced type 2 diabetes ICR male mice were fed normal or HFD supplemented with high fi ber by-products (soybean bran or okara) for eight weeks, to validate the hypothesis that high-fi ber diet would have hypoglycemic effects on diabetic mice, and to provide experimental evidence for developing suitable foods for type 2 diabetes mellitus patients from the high-fi ber diet.
It is well known that polyuria, polydipsia, polyphagia and weight loss represent the initial signs of diabetes in humans as well as in animal models [Kavey et al., 2006] . The quantities of food and water intake of diabetic mice were much higher than these of the normal mice [Lim & . The present results demonstrated that there was a signifi cant increase of food intake in HF-OKG compared to HF-SBG during the whole experimental period. It indicated that the addition of okara could increase the diet's palatability. Thirst in diabetic status is mainly caused by degenerative changes in metabolism [Lim & . In this study, the amount of water consumption was signifi cantly lower in HF-OKG and HF-SBG than DCG. It indicated that the increase of okara and soybean bran in the diet would impact a decrease in water consumption.
STZ-induced diabetes is associated with a severe reduction in body weight, due to the degradation or loss of structural proteins that are obviously known to contribute to the body weight [Li et al., 2011] . During this study, DCG continued to lose weight and NCG continued to gain weight and this agreed with results of Ahmed et al. [2010] , who found a sig- nifi cant difference between normal control mice and diabetic control mice body weight. A gradual increase in body weight was observed in HF-OKG, HF-SBG and HF-MEG due to an improvement in diabetes control and alleviating of diabetes--associated weight loss. The HF-SBG showed considerably lower body weight than the HF-OKG, suggesting that soybean bran could control the increase in body weight of mice under HFD condition. Finger millet bran supplementation prevented body weight gain in HFD-fed mice [Murtaza et al., 2014] . The mechanisms, by which fi ber sources lower body weight, are associated with raising satiety, reducing hunger, providing a feeling of fullness and playing a role in the control of energy balance [Schroeder et al., 2013] .
Feeding okara and soybean bran resulted in a remarkable fall in FBG level in the experimentally-induced type 2 diabetes ICR mice, compared to diabetic control mice. This effect was higher in HF-OKG than HF-SBG. The benefi cial effect of okara on reducing the blood glucose level was due to its content of dietary fi ber [Lu et al., 2013] and also its protein content [Ahmad et al., 2010] . The postprandial serum glucose level of mice fed with soybean bran was distinctly slower than others fed the diet without fi ber, probably due to its high amount of dietary fi ber [Mahalko et al., 1984] . The soybean dietary fi ber contains bioactive components with high viscosity, while these components could delay gastric emptying and glucose absorption [Chang et al., 2008] . Therefore, the hypoglycemic effect of okara and soybean bran dietary fi ber could be due to reduced glucose absorption by slowing gastric emptying. The variation of okara and soybean bran effects on FBG might be due to that okara contains more protein than soybean bran and produces some effect on blood glucose levels of mice fed diet containing it.
Impaired glucose tolerance is one of the main characteristics of insulin resistance [Chen et al., 2014] . Soy protein can improve glucose tolerance [Ahmad et al., 2014] . OGTT results showed that okara delayed the increase of postprandial glucose level and signifi cantly reduced postprandial glucose peak versus DCG. However the peak was still considerably higher than that of NCG. The mice fed soybean bran had a higher blood glucose level compared to okara-fed mice. Feeding short chain fructo-oligosaccharides for 4 to 6 weeks improved glucose tolerance in STZ-treated diabetic rats [Cani et al., 2005] .
Consumption of rich oat or barley beta-glucan foods improved insulin response in type 2 diabetes subjects [Zheng et al., 2013] . The same effect was further confi rmed in type 2 diabetic mice model by feeding the resistant maltodextrin [He et al., 2015] . In this study, the immediate decrease of blood glucose concentrations in HF-OKG, HF-SBG and HF-MEG implied the improvement of their sensitive responses to the administered insulin compared to DCG. Moreover, the decrease of the blood glucose effect caused by soybean bran showed a distinct delay compared with okara.
In this study, the supplementation of all treatments increased the serum insulin level of the STZ-induced diabetic mice compared to those fed with HFD alone. Similar improvements occurred also in diabetic rats and mice fed with fenugreek [El Rahman, 2014] and fermented soybean extract [Nam et al., 2012] , which caused an increase in the production of insulin by keeping pancreatic beta cells and encouraging their glucose-dependent insulin secretion. Therefore, the antihyperglycemic activities of okara and soybean bran were associated with an increase in serum insulin level, while okara and soybean bran might probably cause an improvement in insulin sensitivity and subsequent reduction of hyperglycemia and glucotoxicity.
Compared to the normal, the glycogen content of the liver is reduced in individuals with type 2 diabetes [Klover & Mooney, 2004] . In this study, the hepatic glycogen increased signifi cantly in experimentally-induced type 2 diabetes mice fed okara or soybean bran. This might be caused by reactivation of glycogen synthase duo to the increase of insulin secretion. Soluble dietary fi ber fraction from fenugreek administration also increased glycogen content in type 2 diabetic rats [Hannan et al., 2007] , while supplementation with soybean fermented paste, rice bran or phytic acid resulted in a higher content of hepatic glycogen than that of high-fat-fed mice [Chung et al., 2014; Kim et al., 2010] .
Compared to normal, the diabetic mice usually have lower HDL and higher TC, TG, and LDL and this is mainly a consequence of insulin resistance, which affects enzyme and lipid metabolisms [Bardini et al., 2012] . One of the main health benefi ts of dietary fi ber is related to its role as a hypolipidemic agent. Studies investigating the hypolipidemic effect of dietary fi ber showed a potential decrease of lipid anomalies in diabetic mice fed high-fi ber diet [Ismaiel et al., 2016] . Results of the present study demonstrate that feeding okara and soybean bran had a potential hypolipidemic effect by causing signifi cant reduction of serum TC, TG and LDL levels while increasing HDL level to values similar to those in NCG. However, the hypolipidemic effects of okara and soybean bran were less immediate and intensive than that of metformin-treated mice. Okara supplementation increased the messenger RNA (mRNA) expressions of genes related to hepatic β-oxidation resulting in lower serum TC, TG, and LDL in mice [Kim et al., 2016] . Thus okara might regulate lipid metabolism by increasing the fat excretion and decreasing serum lipids.
Cardiovascular disease is more prevalent among patients with type 2 diabetes, and apoB/apoA ratio is the accurate measurable factor to predict cardiovascular risk [Dahlén et al., 2009] . In this study, the apoB/apoA ratio values of all mice in different groups indicated that feeding HFD supplemented with okara, soybean bran or metformin caused a signifi cant decrease in apoB/apoA ratio compared with the diabetic mice fed HFD only. The hypolipidemic effect of okara does not seem to be due only to one component, but rather to the complement action of its dietary fi ber and protein. The main components of okara, dietary fi ber and protein could be related to the total lipids and cholesterol decrease in the plasma [Villanueva et al., 2011] . Previous clinical study targeting the effect of soybean bran on lipid profi le indicated that soy protein intake could decrease intestinal cholesterol absorption, enhance bile acid secretion, increase removal of LDL and reduce hepatic cholesterol content [Ajay et al., 2011] .
Al teration of the internal organ weights indicated occurrence of either pathology or toxicity to these organs. Type 2 diabetes is a chronic disease that affects multiple organ systems and is associated with the generation of reactive oxygen species [Kaneto et al., 2010] , while it can cause oxidative damage, particularly to liver, kidney and heart. The accumulation of liver fat led to an increase in liver weight [Lim & . Insulin resistance increased the hepatic production of TG-rich particles in liver . In this study, okara and soybean bran signifi cantly reduced relative liver weight compared to the DCG, which may be attributed to the decrease of TG levels in the HF-OKG and HF-SBG. Furthermore, diabetes can cause the polyuria, which affects the kidney function, increases the stress and enlarges the kidney [Lim & . Therefore, the weight of kidney with DCG was the highest, because the increase of kidney weight in diabetes was correlated to the increase of protein and lipid synthesis [Moodley et al., 2015] . The reduced kidney relative weight in the HF-OKG and HF-SBG showed the potential improvements of okara and soybean bran on the kidney. Therefore, these effects on those organs were considered a direct evidence of improved diabetic hepatopathies and nephropathies.
Currently, T2DM has become one of the most important causes of liver disease, such as nonalcoholic fatty liver disease, abnormal liver enzymes, hepatocellular carcinoma, cirrhosis and acute liver failure [Tolman et al., 2007] . The degenerative changes in the histology of liver of STZ-induced type 2 diabetic ICR mice were similar to previous observations [Teoh et al., 2008] . Histologically, liver section of STZ--induced diabetic mice showed severe degeneration, necrosis, hepatocellular swelling, infl ammatory cell infi ltrate and a lot of large lipid droplets in the cytoplasm and those symptoms were strongly correlated with insulin resistance [Han et al., 2015] . This damage was partially reversed by feeding okara and soybean bran and was similar to an observation that soybean treatment decreased the pathogenic effect and removed the fatty change in liver of diabetic rats [Amer, 2012] . This result indicated that okara and soybean bran might have the cytoprotective effect. However, soybean bran was more effective than okara in alleviating hepatic cell histological changes.
Metformin is considered the drug of choice for type 2 diabetes treatment, acting by enhancing glucose uptake and insulin sensitivity as well as decreasing rates of glucose production through a reduction of intracellular glucose production [Correia et al., 2008] . A recent research demonstrated that the okara treatment signifi cantly increased the mRNA expression levels of peroxisome proliferator-activated receptors γ (PPARγ), adiponectin and glucose transporter type 4 in the white adipose tissues of Goto-Kakizaki rats and suggested that the okara hypoglycemic effects might be through the PPARγ-mediated pathway [Hosokawa et al., 2016] . Based on the current study results, okara and soybean bran hypoglycemic action might be associated with different mechanisms, such as reducing glucose absorption from intestine, increasing glycogenesis and lipid metabolism, enhancing pancreatic secretion of insulin and recovery of partially destroyed beta cells and increasing peripheral insulin sensitivity.
CONCLUSIONS
In conclusion, okara or soybean bran at a dose of 15% could signifi cantly reduce the blood glucose level, prevent the increase of serum cholesterol, triacylglycerol and low density lipoprotein, reduce liver and kidney weights, and improve hepatic pathological symptoms in experimentally-induced type 2 diabetes ICR mice. Results indicated that okara and soybean bran could potentially offer the benefi cial features for the T2DM patients.
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